Gemalto is now part of the Thales Group, find out more.
Contact Us


Two-Factor Authentication for EPCS Compliance

Intro Paragraph (optional)

To comply with the DEA’s Electronic Prescriptions for Controlled Substances (EPCS) regulation, medical practitioners need to re-authenticate to their EHR system using two-factor authentication. With state deadlines quickly approaching, SafeNet lets hospitals and healthcare organizations implement EPCS easily, without changing their current infrastructure.

Infographic Electronic Prescription of Controlled Substances Compliance Infographic

Infographic Download (pdf) EPCS Compliance Infographic

Key Stat 1 (Fill In As Many As Required)

What is EPCS? EPCS is a regulation issued by the DEA, requiring medical practitioners to re-authenticate to their EHR system using two-factor authentication, each time they issue an eRx for a controlled substance.


Key Stat 2

Who needs to comply with EPCS? Compliance is required of medical practitioners who issue eRx’s for controlled substances.


Key Stat 3 

When is EPCS compliance due? State deadlines vary, with some mandating compliance by year end 2015. To qualify for financial incentives, organizations can also leverage EPCS to more easily demonstrate State 2 Meaningful Use.


Key Stat 4 

How do you choose a 2FA solution for gaining EPCS compliance? Seek a solution that offers FIPS-validated tokens, quick deployment and low day-to-day operational overhead, while allowing you to keep within budget and evolve your IT ecosystem over time.


Key Stat 5 


Key Stat 6 


Key Stat 7 


Key Stat 8 



Download Infographic (PDF)

Key Points/Stats from this Infographic:

View More Infographics
Back to Top

Contact Us

Thank you for your interest in our products. Please fill out and submit the form to receive more information about Gemalto or to be contacted by a Gemalto specialist.

Your Information

* Email Address:  
* First Name:  
* Last Name:  
* Company Name:  
* Phone:  
* Country:  
* State (US Only):  
* Province (Canada/Australia Only):  

By submitting this form I agree to receive information from Gemalto and its affiliates as described in our Privacy statement.